Skip to main content

Hospital Pharmaceuticals Market Opportunity Assessment and Forecast up to 2023

Jolted by the economic slowdown and the looming patent expiry of blockbuster drugs, the global hospital pharmaceuticals market is forecasted to exhibit a moderate CAGR of 3.9% between 2015 and 2023. Nevertheless, the increasing prevalence of chronic ailments worldwide, coupled with increasing healthcare spending is expected to keep the demand for hospital pharmaceuticals high in the near future. As per Transparency Market Research, the market stood at US$197.3 bn in 2014 and is expected to reach US$280.3 bn by the end of 2023. Emerging economies in Asia Pacific and Rest of the World are currently exhibiting highest demand for hospital pharmaceuticals.
As per reports from the World Health Organization (WHO), annual cases of cancer globally are expected to reach 22 million by 2030. This combined with the rising incidence of parasitic infections will boost demand for anti-parasitic drugs, thus driving the global hospital pharmaceuticals market in the forthcoming years.
Increasing Pharmaceuticals Spending in U.S. Boosts Prospects of Hospital Pharmaceuticals in North America
Regionally, North America held the largest share in the global market in 2014. The recovery of the pharmaceutical industry and the rise in R&D activities between 2013 and 2014 have bolstered opportunities for the hospital pharmaceuticals market in North America. As per TMR analysis, the increasing spending on pharmaceuticals by the U.S. government has considerably aided in the expansion of the hospital pharmaceuticals market in North America. The market in the region is projected to surge at a CAGR of 3.4% between 2015 and 2023.
Europe has emerged as the second-largest market for hospital pharmaceuticals, primarily due to the presence of renowned research organizations in the region. The sound intellectual property protection norms prevalent in Europe have also helped the market to thrive in the region. However, the region lacks proper reimbursement policies and regulatory framework for encouraging the development of novel therapeutics. This could restrain the market’s growth in Europe.
Request the Coronavirus Impact Analysis on this Market –   https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3535
In the meantime, surging opportunities in Latin America and Asia Pacific will compel vendors to shift their focus from developed economies to emerging nations. The large population base in Asia Pacific, coupled with the increasing spending on research and development of novel therapeutics will aid expansion of the hospital pharmaceuticals market in emerging economies.
Demand from Oncology Segment to Surge in Response to Increasing Incidence of Cancer
The increasing incidence of cancer worldwide has catapulted the oncology segment at the forefront of the global hospital pharmaceuticals market, by therapeutic class. Cancer types such as stomach, breast, liver, and lung cancer have emerged as the leading causes of deaths due to cancer. The market is forecasted to gain momentum from a strong product pipeline as more drugs receive FDA approvals in the future. Since cancer is often associated with a high mortality rate, scientists around the world are engaged in the discovery of better treatment options and more efficient drugs. Demand for oncology drugs is therefore expected to surge in the forthcoming years. TMR has pegged the oncology segment in the global hospital pharmaceuticals market to rise at a CAGR of 6.35% during the forecast period.
Besides this, the increasing incidence of cardiovascular diseases will also fuel demand from the global hospital pharmaceuticals market. The increasing government initiatives, growing diseases awareness, and therapeutic interventions aimed at curbing the incidence of cardiovascular ailments are likely to boost demand for relevant hospital pharmaceuticals.
Demand for anti-hypersensitive drugs is also expected to increase during the forecast period.
Some of the most prominent vendors operating in the global hospital pharmaceuticals market include Novartis, Pfizer, Roche, Sanofi, Merch &Co., AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Gilead Sciences, and others.

Comments

Post a Comment

Popular posts from this blog

Angioplasty Balloons & Stents Market Research Report | Forecast Until 2027

Complications with Existing Treatments to Drive Innovations The healthcare sector is no stranger to innovations and technological advancements. Research and development activities continue to improve the efficacy of treatments and bring forward new therapies to treat a range of diseases. Over the past couple of decades, minimally invasive procedures have gained a great amount of popularity within the healthcare sector. A similar trend can be observed within the angioplasty balloons & stents market as the adoption of minimally invasive procedures is on the rise, particularly among patients who have been diagnosed with coronary heart diseases or experienced a heart attack. Request Sample Of Report –   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5627 At present, healthcare experts are focusing on minimizing the complications involved with the percutaneous coronary intervention (PCI) by leveraging the benefits of technology that conti...
Post a Comment
Read more

Autoimmune Disease Diagnostics Market Analysis and Forecast up to 2023

Autoimmune Disease Diagnostics Market – Snapshot When immune system attacks the body mistakenly, then the resulting condition is known as autoimmune disease. Some of the autoimmune diseases are found more commonly in certain ethnicities than others. A case in point is high prevalence of lupus amongst the Hispanic and African-American group of people rather than Caucasians. The global autoimmune disease diagnostics market is estimated to make substantial gains due to rising incidences of autoimmune diseases across the globe. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351 Some of the autoimmune diseases such as lupus and multiple sclerosis run within families. In that case, the family members will inherit vulnerability to the autoimmune illness that runs in the family but might not necessarily be affected by it. Increased Prevalence of Autoimmune Diseases to Spell Growth of the Market Many of the auto...
Post a Comment
Read more

Analysis of COVID-19 Collagen Peptide and Gelatin Market

Collagen Peptide and Gelatin Market: Overview According to Transparency Market Research’s latest report on the global collagen peptide and gelatin market for the historical period  2017–2018  and forecast period  2019–2027 , increase in commercialization of novel collagen-based drug delivery systems and rise in social awareness about personal well-being are projected to drive the global collagen peptide and gelatin market According to the report, the global collagen peptide and gelatin market was valued at  US$ 5,976.9 Mn  in  2018  and is projected to expand at a CAGR of  8.7%  from  2019  to  2027 To know the scope of our report  Get a Sample  on Collagen Peptide and Gelatin Market Increase in social awareness about personal well-being and rigorous research and development activities in regenerative medicine and wound healing: Key Drivers Major factors driving the collagen peptide application in nutrac...
Post a Comment
Read more